News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tikvah Therapeutics to Present At Lazard Capital Markets Healthcare Conference On November 27



11/16/2007 1:06:23 PM

ATLANTA, Nov. 16, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., an Atlanta, GA-based biopharmaceutical company focused on new treatment options to better manage central nervous system diseases, announced today that Dr. Harold H. Shlevin, president and chief executive officer of Tikvah, is scheduled to present at the Lazard Capital Markets Fourth Annual Healthcare Conference. The presentation will take place in New York on Tuesday, November 27, 2007, at 9:00 am EST.

Read at press release

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES